Caregivers-at-home: The Ignored Heroes in the Patient Journey Vivek Hattangadi31 Jan 2022 2:27 PM ISTAny count on the caregivers at home? And the cost or the value of the free services they render to near and dear patients? It's anybody's guess. ...
Levodopa-Induced Dyskinesia in Parkinson's disease: Amantadine to Sheath the Double-edged Sword Dr. Nupur Rajoria31 Jan 2022 10:47 AM ISTParkinson's disease (PD) is a movement disorder and the second most common neurodegenerative disorder in adults over the age of 60 years (1). India is...
Clinical Utility of Doxycycline in Chronic Obstructive Pulmonary Disease (COPD) Infections: Review of Indian Experience Dr Suresh Ade29 Jan 2022 12:03 PM ISTChronic obstructive pulmonary disease (COPD) is a disease affecting the pulmonary airways with inflammation; pathologically characterized by its...
Battling Lower Respiratory Tract Infections: Scope of Levofloxacin Dr. Kamal Kant Kohli27 Jan 2022 10:27 AM ISTFluoroquinolones are highly effective antibiotics with many advantageous pharmacokinetic properties including high oral bioavailability, a large...
Molnupiravir (MK-4482/EIDD-2801) inhibits SARS-CoV-2 replication in Syrian Hamster Model Dr. Kamal Kant Kohli25 Jan 2022 11:04 AM ISTAn effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in...
Review: The complex liaison of Nicotine and Diabetes and role of NRT Dr. Shivi Kataria24 Jan 2022 11:45 AM ISTSmoking tobacco has been linked with diabetes for the last two decades backed by sound research data. The detrimental effects of cigarette smoking on...
Revisiting the need for Early management of Influenza: Role of Oseltamivir Dr. Kamal Kant Kohli20 Jan 2022 11:33 AM ISTInfluenza, commonly known as flu, is a contagious viral infection caused mainly due to influenza viruses A and B (1). It usually attacks the...
Understanding Monoclonal Antibody in Treatment of Hospitalized Patients with COVID-19 Dr. Kamal Kant Kohli18 Jan 2022 12:45 PM ISTHospitalized COVID-19 patients reported having high mortality rates (10-30%). Casirivimab and imdevimab antibody cocktail (REGEN-COV®) are authorized...
Are probiotics the new gold standard in managing Helicobacter pylori infections? Dr Suresh Ade17 Jan 2022 12:35 PM ISTHelicobacter pylori (H. pylori) infection is considered one of the most common bacterial infections reported globally, especially in Eastern Europe,...
Molnupiravir Blocks SARS-CoV-2 Transmission in Ferrets Dr. Kamal Kant Kohli14 Jan 2022 11:19 AM ISTThe coronavirus disease (COVID)-19 pandemic is exerting a global impact on human health. Interrupting widespread community transmission is paramount...
Disease Review: Understanding Incidence of Idiopathic pulmonary fibrosis (IPF) in India, Diagnosis and Treatment Dr. Anil Mehndiratta10 Jan 2022 12:24 PM ISTIdiopathic pulmonary fibrosis (IPF), previously known as "Hamman Rich syndrome", "cryptogenic fibrosing alveolitis", and "cirrhosis of the lung", is a...
Breakthrough COVID-19 Infections: Decoding scope of Monoclonal Antibody Dr. Kamal Kant Kohli7 Jan 2022 10:46 AM ISTDespite the effectiveness of COVID-19 vaccines, breakthrough infections have been reported. Breakthrough COVID-19 may occur in fully vaccinated...
